CerimmuPro
Natural health product licensed in Canada
- Licence holder
- Amark Academy Inc.
- NPN or DIN-HM
- 80087328
- Status
- Active licence
- Licence date
- 23 July 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Panax ginseng Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 250 mg | 50 mg | Not calculated |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 500 mg Potency : 80 % Oligomeric proanthocyanidins | 50 mg | Not calculated |
| Cinnamomum aromaticum Source : Écorce (branche) Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 200 mg | 20 mg | Not calculated |
| Astragalus membranaceus Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1 g | 100 mg | Not calculated |
| Lycium barbarum Source : Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 800 mg | 80 mg | Not calculated |
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 2,500 mg Potency : 6 % Terpene lactones | 50 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Graine de citrouille, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Astragalus is used in Herbal Medicine to help enhance a healthy immune system. Ginkgo biloba helps to enhance cognitive function and memory in adults and to support peripheral circulation. Panax Ginseng helps support cognitive function and/or reduce mental fatigue (in cases of mental stress). Panax Ginseng is used in Herbal Medicine as supportive therapy for the promotion of healthy glucose levels. Source of antioxidant.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a healthcare practitioner prior to use if you are pregnant or breastfeeding. Consult a healthcare practitioner prior to use if you have an auto-immune disorder. Consult a healthcare practitioner prior to use if you are taking antidepressant medications. Consult a healthcare practitioner prior to use if you are taking blood thinners or digoxin. Consult a healthcare practitioner prior to use if you have diabetes. Consult a healthcare practitioner prior to use if you are taking medications for diabetes, high blood pressure, or seizures.
- Contre-indications
According to TCM, do not use in cases of yin deficiency with heat signs, heat excess, or in the absence of significant qi deficiency. Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen), as this may increase the risk of spontaneous bleeding.
- Effets indésirables connus
Hypersensitivity/allergy may occur; in which case, discontinue use. Some people may experience insomnia, anxiety, or headaches, in which case, discontinue use.
Source
Official Health Canada record, licence 80087328
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.